Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin associated protein 4-17, pseudogene (KRTAP4-17P, also known as KRTAP4p3) is a non-protein-coding member of the keratin-associated protein gene family. The KRTAP genes typically participate in the structural matrix of hair, combining with keratin intermediate filaments to provide strength and rigidity to hair fibers. However, pseudogenes such as KRTAP4-17P contain disabling mutations or deletions that prevent them from producing functional proteins, so they play no role in normal protein function, signaling, or disease pathology. Updated naming conventions highlight the "p" suffix to distinguish pseudogenes from coding KAPs, and current knowledge recognizes that pseudogenes are not considered therapeutic or diagnostic targets[5][6][8].
None (no drug mechanisms; not an actionable biological entity)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin associated protein 4-17, pseudogene (KRTAP4-17P).